Beta Bionics Operating Expenses 2024-2025 | BBNX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Beta Bionics operating expenses from 2024 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Beta Bionics operating expenses from 2024 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$186.1B
Intuitive Surgical (ISRG)	$169.7B
IDEXX Laboratories (IDXX)	$51.8B
Edwards Lifesciences (EW)	$47.8B
Alcon (ALC)	$39.4B
IQVIA Holdings (IQV)	$32.4B
DexCom (DXCM)	$29.5B
Mettler-Toledo (MTD)	$26.8B
STERIS (STE)	$24.1B
Waters (WAT)	$18B
SONOVA HOLDING (SONVY)	$17.4B
Hologic (HOLX)	$14.9B
Penumbra (PEN)	$10.6B
Globus Medical (GMED)	$8.3B
Sysmex ADR (SSMXY)	$7.9B
Masimo (MASI)	$7.6B
Teleflex (TFX)	$5.6B
Glaukos (GKOS)	$5.5B
TransMedics (TMDX)	$3.9B
Integer Holdings (ITGR)	$3.8B
LivaNova (LIVN)	$3.1B
Veracyte (VCYT)	$2.4B
Alphatec Holdings (ATEC)	$2.4B
PROCEPT BioRobotics (PRCT)	$2.2B
Artivion (AORT)	$2.1B
Nihon Kohden (NHNKY)	$2B
Elekta AB (EKTAY)	$1.8B
Integra LifeSciences Holdings (IART)	$1.2B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B